Bill

Bill > HB3833


OK HB3833

OK HB3833
Blood autologous; Oklahoma Autologous and Directed Blood Donation Act; terms; physician orders; hospital responsibilities; blood bank responsibilities; administrative fees; liability protections; promulgation of rules; State Department of Health; effective date.


summary

Introduced
02/02/2026
In Committee
02/03/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

An Act relating to blood autologous; creating the Oklahoma Autologous and Directed Blood Donation Act; defining terms; providing for physician orders; directing hospital responsibilities; establishing blood bank responsibilities; providing for administrative fees; establishing liability protections; directing for the promulgation of rules by the State Department of Health; providing for noncodification; providing for codification; and providing an effective date.

AI Summary

This bill, known as the Oklahoma Autologous and Directed Blood Donation Act, establishes guidelines for the use of blood donated by patients for their own future use (autologous donation) or by individuals specifically for a named patient (directed donation). It requires hospitals and blood banks to honor a physician's written order for such donations for scheduled medical procedures, provided the donor meets all standard eligibility and safety requirements, the request is made with sufficient advance notice (at least 72 hours, or as otherwise defined by the State Department of Health), and the correct blood unit is available. Hospitals are directed to permit these donations when ordered by a physician and to coordinate with blood banks to ensure proper handling and availability, without denying their use based on internal policies if all criteria are met. Blood banks must collect, process, store, and make these donations available according to federal and state standards, complying with physician orders and maintaining the integrity of the blood units through proper tracking and labeling. The act allows hospitals and blood banks to charge reasonable administrative fees for the special handling of these donations, which should be disclosed to patients when possible. It also provides liability protections for hospitals and blood banks if a requested autologous or directed blood unit is unavailable due to donor ineligibility, testing unsuitability, expiration, or other circumstances beyond their control. Finally, the State Department of Health is tasked with creating necessary rules to implement this act within 180 days of its effective date, ensuring these rules do not exceed existing federal blood-handling standards and involve consultation with relevant stakeholders.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

House Public Health Hearing (08:00:00 2/11/2026 Room 206) (on 02/11/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...